Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 405

1.

Effects of orexin A on GLUT4 expression and lipid content via MAPK signaling in 3T3-L1 adipocytes.

Shen Y, Zhao Y, Zheng D, Chang X, Ju S, Guo L.

J Steroid Biochem Mol Biol. 2013 Nov;138:376-83. doi: 10.1016/j.jsbmb.2013.07.005. Epub 2013 Jul 29.

PMID:
23907013
2.

Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes.

Skrzypski M, T Le T, Kaczmarek P, Pruszynska-Oszmalek E, Pietrzak P, Szczepankiewicz D, Kolodziejski PA, Sassek M, Arafat A, Wiedenmann B, Nowak KW, Strowski MZ.

Diabetologia. 2011 Jul;54(7):1841-52. doi: 10.1007/s00125-011-2152-2. Epub 2011 Apr 21.

PMID:
21505958
3.

Effects of orexin A on proliferation, survival, apoptosis and differentiation of 3T3-L1 preadipocytes into mature adipocytes.

Skrzypski M, Kaczmarek P, Le TT, Wojciechowicz T, Pruszyńska-Oszmalek E, Szczepankiewicz D, Sassek M, Arafat A, Wiedenmann B, Nowak KW, Strowski MZ.

FEBS Lett. 2012 Nov 30;586(23):4157-64. doi: 10.1016/j.febslet.2012.10.013. Epub 2012 Oct 30.

4.

Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.

Bazuine M, Carlotti F, Tafrechi RS, Hoeben RC, Maassen JA.

Mol Endocrinol. 2004 Jul;18(7):1697-707. Epub 2004 Apr 15.

PMID:
15184525
5.

Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation.

Huang YC, Chang WL, Huang SF, Lin CY, Lin HC, Chang TC.

Eur J Pharmacol. 2010 Dec 1;648(1-3):39-49. doi: 10.1016/j.ejphar.2010.08.021. Epub 2010 Sep 9.

PMID:
20816811
6.

Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes.

Yamamoto Y, Yoshimasa Y, Koh M, Suga J, Masuzaki H, Ogawa Y, Hosoda K, Nishimura H, Watanabe Y, Inoue G, Nakao K.

Diabetes. 2000 Mar;49(3):332-9.

PMID:
10868953
7.

Substance P decreases fat storage and increases adipocytokine production in 3T3-L1 adipocytes.

Miegueu P, St-Pierre DH, Lapointe M, Poursharifi P, Lu H, Gupta A, Cianflone K.

Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G420-7. doi: 10.1152/ajpgi.00162.2012. Epub 2012 Dec 20.

8.
9.

Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.

Choi SS, Cha BY, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT.

Life Sci. 2009 Jun 19;84(25-26):908-14. doi: 10.1016/j.lfs.2009.04.001. Epub 2009 Apr 17.

PMID:
19376135
10.

Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK.

Wang YQ, Yao MH.

J Nutr Biochem. 2009 Dec;20(12):982-91. doi: 10.1016/j.jnutbio.2008.09.002. Epub 2009 Feb 5.

PMID:
19195868
11.

Effects of inorganic HgCl2 on adipogenesis.

Barnes DM, Hanlon PR, Kircher EA.

Toxicol Sci. 2003 Oct;75(2):368-77. Epub 2003 Jul 25.

PMID:
12883084
12.

Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes.

Kim ED, Kim E, Lee JH, Hyun CK.

Eur J Pharmacol. 2011 Jan 10;650(1):479-85. doi: 10.1016/j.ejphar.2010.10.006. Epub 2010 Oct 14.

PMID:
20951125
13.

Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways.

González-Yanes C, Serrano A, Bermúdez-Silva FJ, Hernández-Dominguez M, Páez-Ochoa MA, Rodríguez de Fonseca F, Sánchez-Margalet V.

Am J Physiol Endocrinol Metab. 2005 Nov;289(5):E923-9. Epub 2005 May 10.

14.

Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes.

Furukawa H, Mawatari K, Koyama K, Yasui S, Morizumi R, Shimohata T, Harada N, Takahashi A, Nakaya Y.

Eur J Pharmacol. 2011 Jun 25;660(2-3):485-91. doi: 10.1016/j.ejphar.2011.04.008. Epub 2011 Apr 15.

PMID:
21514293
15.

A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation.

Somwar R, Koterski S, Sweeney G, Sciotti R, Djuric S, Berg C, Trevillyan J, Scherer PE, Rondinone CM, Klip A.

J Biol Chem. 2002 Dec 27;277(52):50386-95. Epub 2002 Oct 21.

16.

Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.

Yamaguchi S, Katahira H, Ozawa S, Nakamichi Y, Tanaka T, Shimoyama T, Takahashi K, Yoshimoto K, Imaizumi MO, Nagamatsu S, Ishida H.

Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E643-9. Epub 2005 May 31.

17.

Phytic acid and myo-inositol support adipocyte differentiation and improve insulin sensitivity in 3T3-L1 cells.

Kim JN, Han SN, Kim HK.

Nutr Res. 2014 Aug;34(8):723-31. doi: 10.1016/j.nutres.2014.07.015. Epub 2014 Jul 30.

PMID:
25174657
18.

MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytes.

Harmon AW, Paul DS, Patel YM.

Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E758-66. Epub 2004 Jun 1.

19.

Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytes.

Zang K, Wang J, Dong M, Sun R, Wang Y, Huang Y, Liu X, Li Y, Wang F, Yu M.

PLoS One. 2013 Oct 23;8(10):e78536. doi: 10.1371/journal.pone.0078536. eCollection 2013.

20.

Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes.

Kim KJ, Lee OH, Lee BY.

Life Sci. 2010 May 22;86(21-22):791-7. doi: 10.1016/j.lfs.2010.03.010. Epub 2010 Mar 25.

PMID:
20346961

Supplemental Content

Support Center